Methods for detecting Norovirus
AssigneeQuest Diagnostics Investments Incorporated
InventorsPeter Lee, Raymond Huang, Kristin Ramos, Jules Chen, Michelle Tabb
Life of this patent
Estimating the term…
Loading patent…
AssigneeQuest Diagnostics Investments Incorporated
InventorsPeter Lee, Raymond Huang, Kristin Ramos, Jules Chen, Michelle Tabb
Estimating the term…
The present disclosure provides methods and compositions for determining whether a patient exhibiting acute gastroenteritis will benefit from treatment with therapeutic agents that inhibit Norovirus genogroup I (GI) or Norovirus genogroup II (GII). The methods disclosed herein are based on detecting Norovirus genogroup I (GI) and Norovirus genogroup II (GII) in a stool sample without extracting viral nucleic acids from a clinical specimen prior to performing real-time reverse transcription PCR. Kits for use in practicing the methods are also provided.
A method for detecting the presence of Norovirus genogroup I (GI) in a stool sample comprising:
A method for detecting the presence of Norovirus genogroup II (GII) in a stool sample comprising:
A method for selecting a patient suffering from acute gastroenteritis for treatment with a therapeutic agent that inhibits Norovirus genogroup II (GII) comprising:
Dependencies are inferred from the claim text.